Abstract
The present study was aimed to evaluate the anticancer behaviour of the biogenic and chemically synthesized gold nanoparticles (GNPs) towards cancerous (HeLa, MCF-7, A549 and H1299) and normal (HEK293) cell lines. We observed that biologically synthesized particles were spherical with average size ranging from 2 to 10 nm, whereas the chemically synthesized particles were polydispersed with average size ranging from 5 to 20 nm. SEM analysis suggested the crystalline behaviour of the synthesized particles. Imaging results revealed that the particles were able to penetrate the cells with localization in cytosol or in the nucleus. Cell viability assay suggested the biologically synthesized particles significantly inhibited the growth of cancerous cells in a dose dependent manner with an IC50 value of around 200 µg/mL and were found to be non-toxic towards normal cells (HEK293). While the citrate capped particles were observed to be able to kill only around 20–25% of cells even at a high concentration of 400 µg/mL. Colony suppression studies, intracellular ROS estimation, cell cycle arrest and deregulation of mitochondrial membrane potential showed the high anticancer efficiency of biologically synthesized particles in comparison to chemically synthesized particles. Based on these observations we confirm Ocimum tenuiflorum extract stabilized GNPs have potentially promising antitumor substrates.
Similar content being viewed by others
References
S. Khazaei, V. Ramachandran, R. Abdul Hamid, et al. (2017). Biomed. Pharmacother.89, 1216.
R. Khanam, R. Kumar, I. I. Hejazi, et al. (2018). Apoptosis23, (2), 113.
World Health Organization (2012). GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. International agency for research on cancer, population fact sheets (Islamic Republic of Iran).
A. A. Alshatwi, V. S. Periasamy, J. Athinarayanan, et al. (2016). Chem. Biol. Interact.247, 1.
R. Thangam, M. Sathuvan, A. Poongodi, et al. (2014). Carbohydr Polym.107, 138.
M. Kodiha and Y. M. Wang Hutter (2015). Theranostics.5, 357.
R. A. Petros and J. M. DeSimone (2010). Nat. Rev. Drug Discov.9, 615.
A. Rai, A. Prabhune, and C. C. Perry (2010). J. Mater. Chem.20, (32), 6789.
G. T. Peng, U. O. Adams, M. Hakim, et al. (2009). Nat. Nanotechnol.4, 669.
M. Saravanan, T. Asmalash, A. Gebrekidan, D. Gebreegziabiher, T. Araya, H. Hilekiros, H. Barabadi, and K. Ramanathan (2018). Pharm. Nanotechnol.6, 17.
H. Barabadi, Z. Alizadeh, M. T. Rahimi, A. Barac, A. E. Maraolo, L. J. Robertson, A. Masjedi, F. Shahrivar, and E. Ahmadpour (2019). Nanomed. NBM18, 221.
D. T. Thompson (2007). Nano Today.2, 40.
S. D. Perrault and W. C. W. Chan (2010). Proc. Natl. Acad. Sci.107, 11194.
P. K. Sarkar and A. K. Chaudhary (2010). J. Sci. Ind. Res.69, 901.
S. Alex and A. Tiwari (2015). J. Nanosci. Nanotechnol.15, 1869.
B. Krishna and G. Dan (2009). J. Mater. Res.24, 2828.
R. M. Tripathi, A. Saxena, N. Gupta, et al. (2010). Digest J. Nanomater. Biostruct.5, 427.
A. Taleb, C. Petit, and M. P. Pilen (1997). Chem. Mater.9, 950.
P. Mukherjee, A. Ahmad, D. Mandal, et al. (2001). Nano Lett.1, 515.
S. Salari, S. Esmaeilzadeh Bahabadi, A. Samzadeh-Kermani, and F. Yousefzaei (2019). Iran. J. Pharm. Res.18, 430.
Z. Rezvani Amin, Z. Khashyarmanesh, B. S. Fazly Bazzaz, and Z. Sabeti Noghabi (2019). Iran. J. Pharm. Res.18, 210.
T. Ramezani, M. Nabiuni, J. Baharara, K. Parivar, and F. Namvar (2019). Iran. J. Pharm. Res.18, 222.
H. Barabadi, F. Kobarfard, and H. Vahidi (2018). Iran. J. Pharm. Res.17, 87.
M. Maham and R. Karami-Osboo (2017). Iran. J. Pharm. Res.16, 462.
N. Karimi, A. Chardoli, and A. Fattahi (2017). Iran. J. Pharm. Res.16, 1167.
R. Dobrucka (2017). Iran. J. Pharm. Res.16, 753.
A. Chahardoli, N. Karimi, and A. Fattahi (2017). Iran. J. Pharm. Res.16, 1169.
Q. Abbas, M. Saleem, A. R. Phull, M. Rafiq, M. Hassan, K.-H. Lee, and S.-Y. Seo (2017). Iran. J. Pharm. Res.16, 760.
M. M. Or Rashid, M. S. Islam, M. A. Haque, M. A. Rahman, M. T. Hossain, and M. A. Hamid (2016). Iran. J. Pharm. Res.15, 591.
H. Barabadi and S. Honary (2016). Pharm. Biomed. Res.2, 1.
M. Kasithevar, M. Saravanan, P. Prakash, H. Kumar, M. Ovais, H. Barabadi, and Z. K. Shinwari (2017). J. Interdiscip. Nanomed.2, 131.
H. Barabadi, S. Honary, P. Ebrahimi, A. Alizadeh, F. Naghibi, and M. Saravanan (2019). Inorg. Nano-Met. Chem.49, 33.
P. N. Aniwal, C. M. Bellurkar, and P. B. Bhosale (2006). J. Dairy. Foods Home Sci.25, 218.
P. Pattanayak, P. Behera, D. Das, et al. (2010). Pharmacogn. Rev.4, (7), 95.
P. Prakash and N. Gupta (2005). Indian J. Physiol. Pharmacol.49, (2), 125.
E. H. M. Hussain, K. Jamil, and M. Rao (2001). Indian J. Clin. Biochem.16, (2), 190.
F. Aqil, R. Munagala, J. Jeyabalan, et al. (2012). Cancer Lett.334, 133.
M. J. Kadhim, A. A. Sosa, and I. H. Hameed (2016). J. Pharmacogn. Phytother.8, (6), 127.
V. Kumar and S. K. Yadav (2009). J. Chem. Technol. Biotechnol.84, 151.
K. N. Thakkar, S. S. Mhatre, and R. Y. Parikh (2010). Nanomedicine6, 257.
M. Brust, M. Walker, D. Bethell, D. J. Schiffrin, et al. (1997). J. Chem. Soc. Chem. Commun.7, 801.
W. Haiss, N. T. K. Thanh, J. Aveyard, et al. (2007). Anal Chem.79, 4215.
J. Zheng, C. Zhang, and R. M. Dickson (2004). Phys. Rev. Lett.93, (7), 077402.
P. K. Gautam, S. Kumar, M. S. Tomar, et al. (2017). J. Cell Sci. Ther.8, 6.
M. R. Kamala Priya and P. R. Iyer (2015). Appl. Nanosci.5, 443.
D. Beaudet, S. Badilescu, K. Kuruvinashetti, et al. (2017). Sci. Rep.7, 10678.
H. U. Simon, A. Haj-Yehia, and F. Levi-Schaffe (2000). Apoptosis5, 415.
Acknowledgements
EP acknowledges DST-SERB, Government of India for National Post-Doctoral Fellowship (PDF/2017/000024). This research was supported by a DST-PURSE-II funding. We are thankful to the Advanced Research Instrumentation Facility (AIRF) of the University for allowing us access to their facilities. The project work was funded by UPE-II project ID 357.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Virmani, I., Sasi, C., Priyadarshini, E. et al. Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles. J Clust Sci 31, 867–876 (2020). https://doi.org/10.1007/s10876-019-01695-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-019-01695-5